(Westbury, NY— November 2020) Fran Zipp, Past International Board Chair, ISPE and CEO of Lachman Consultants is scheduled to deliver opening remarks at the 2020 ISPE Singapore Affiliate Conference & Exhibition. The three-day virtual event featuring programs, seminars, leading-edge technology, and presentations by top industry experts will take place Wednesday, December 9th through Friday, December 11th.

Lachman Consultants is an Advertising Sponsor of the event, which offers immersive virtual broadcasting and networking, to make the conference globally accessible to pharma industry attendees. ISPE Singapore Affiliate Conference & Exhibition 2020 features more than sixty virtual livestream sessions, on-demand content, and a virtual exhibition, showcasing product demos and networking opportunities.

Offering her unique insights acquired as both ISPE past chair and acknowledged industry leader, Ms. Zipp’s comments will offer perspectives covering regional and global pharmaceutical industry advancements, trends, and opportunities, as well as an outlook on the coming year.

In her leadership role as CEO of Lachman Consultants, Ms. Zipp has overseen the growth and expansion of the organization into new areas of service and support in compliance, regulatory affairs, and technical services to clients around the world. Among them are a variety of timely and innovative compliance and regulatory delated services created to overcome challenges created during the current health crisis. This includes an on-call consultation program and virtual reality inspections enabling clients to have their facilities inspected remotely by a Lachman Consultants’ specialist.

Reflecting on her time as International Board Chair, Ms. Zipp says, “The ISPE has demonstrated a dynamic resilience during the past year which is reflective of the commitment and dedication of our members to move the organization ahead with purpose. In the year ahead, I am optimistic that we will all be back together again. Until then, I encourage our ISPE members to continue to reach out to their colleagues through Knowledge Networks and WIP circles.”



Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver highly effective and proven solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which have been shown to consistently exceed client requirements and expectations.

For additional press information, please contact:
Ilena Della Ventura
Delia Associates
T. 908-534-9044
E. Idellaventura@delianet.com
W. https://www.delianet.com